Cerity Partners LLC Boosts Stake in Corteva, Inc. (NYSE:CTVA)

Cerity Partners LLC lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 27.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,759 shares of the company’s stock after acquiring an additional 11,034 shares during the quarter. Cerity Partners LLC’s holdings in Corteva were worth $2,480,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of CTVA. CVA Family Office LLC purchased a new stake in shares of Corteva during the 4th quarter worth about $25,000. BKM Wealth Management LLC purchased a new position in Corteva in the 4th quarter valued at about $27,000. NewSquare Capital LLC lifted its stake in Corteva by 70.6% in the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock valued at $28,000 after buying an additional 226 shares in the last quarter. Glass Jacobson Investment Advisors llc lifted its stake in Corteva by 234.3% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock valued at $28,000 after buying an additional 389 shares in the last quarter. Finally, Cornerstone Planning Group LLC purchased a new position in Corteva in the 2nd quarter valued at about $28,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Up 0.8 %

Corteva stock opened at $53.96 on Friday. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $62.97. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56. The firm has a 50 day moving average price of $55.20 and a 200 day moving average price of $50.26. The company has a market capitalization of $37.71 billion, a PE ratio of 52.90, a price-to-earnings-growth ratio of 1.40 and a beta of 0.77.

Corteva (NYSE:CTVA) last posted its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The firm had revenue of $3.71 billion during the quarter, compared to the consensus estimate of $3.54 billion. During the same quarter last year, the firm earned $0.16 EPS. Research analysts expect that Corteva, Inc. will post 2.84 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were issued a $0.16 dividend. The ex-dividend date was Thursday, February 29th. This represents a $0.64 annualized dividend and a yield of 1.19%. Corteva’s dividend payout ratio (DPR) is presently 62.75%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CTVA shares. Loop Capital raised shares of Corteva from a “hold” rating to a “buy” rating and raised their price target for the company from $57.00 to $65.00 in a research note on Monday, February 12th. TheStreet raised shares of Corteva from a “c+” rating to a “b-” rating in a research note on Tuesday, February 27th. UBS Group decreased their price target on shares of Corteva from $65.00 to $64.00 and set a “buy” rating on the stock in a research note on Thursday, January 11th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $57.00 price target (down from $58.00) on shares of Corteva in a research note on Friday, April 12th. Finally, Wolfe Research initiated coverage on shares of Corteva in a report on Friday, March 1st. They issued an “outperform” rating and a $67.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $63.29.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.